Is my portfolio
One Report to Answer all your Questions!
Alembic Pharmaceuticals Ltd.
BSE: 533573 | NSE: APLLTD
Small Cap | Pharmaceuticals & Drugs
863.50
-13.65 (-1.56%) Alembic Pharmaceuticals informs about press release
Date: 26-11-2018Alembic Pharmaceuticals has informed that the company's joint venture, Aleor Dermaceuticals, has received United States Food and Drugs Administration (USFDA) Approval for Lidocaine Ointment USP, 5%. Further, the company has submitted the press release.
The above information is a part of company’s filings submitted to BSE.